Vaccine confusion, the humdrum of SONA

Disappointing news from a trial of the AstraZeneca vaccine against the South African variant of COVID-19 will further complicate vaccination campaigns across the region, and could delay recoveries further. In South Africa, the annual State of the Nation Address (SONA) recounted many of the government’s previously outlined plans to recover from the coronavirus crisis but offered few new initiatives to support the economy.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.
By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.